Supplemental Funding For Regional Prospective Observational Research for Tuberculosis (RePORT) International
ATTENTION: Deadline has been extended until February 18th, 2019 (23:59 EST).
CRDF Global is accepting proposals to fund supplemental research projects related to the RePORT International consortia (India, Brazil, Indonesia, South Africa, China and the Philippines) and their objectives. Funding for this research award initiative is administered by CRDF Global, utilizing funds provided by U.S. National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID), Division of AIDS (DAIDS).
The purpose of RePORT International is to:
- Advance regional TB science which is also relevant in a global, international context with special interest in TB-HIV affected populations.
- Strengthen TB research capacity and infrastructure in high TB and TB-HIV burden settings.
- Serve as an entity to foster research collaboration within each country and internationally, with the aim of carrying out a wide range of basic and clinical research that can lead to clinically important biomarkers, vaccines, drugs, and diagnostics.
The Common Protocol (CP) is a unified protocol that is to be implemented by all RePORT International CRUs. The CP is supported in most countries by a central biorepository, a central data management center (DMC), and the utilization of harmonized data elements and specimen collection standard operating procedures (SOPs). It is envisioned that this will provide TB researchers a harmonized set of clinical data associated with biological specimens which will serve as a valuable resource to address important research questions in TB both locally and across sites. While additional information or specimens might be proposed in the context of this proposal, the CP should be the platform upon which the individual research protocols are formulated in response to this call.
Please find application's electronic proposal submission (EPS) site here: https://eps.crdfglobal.org/REPORT-INTL